The Coriolis Effect
Our Facilities
Leadership Team
Our Journey
Careers

Antibody or Antibody-Related
Peptide
Therapeutic Protein
Gene & Cell Therapy
Viral Vector
Nucleic Acid
Vaccine
Nanoparticulate Delivery Systems

Preclinical
Early-Phase
Late-Phase & Commercialization
Commercial Services

Drug Product Development
Analytical Services
Manufacturing Services

News & Press Releases
Webinars & Events
Scientific Resources
Discover All

The Coriolis Effect
Our Facilities
Leadership Team
Scientific Advisory Board
Our Journey
Our Partner
Careers

Antibody or Antibody-Related
Peptide
Therapeutic Protein
Gene & Cell Therapy
Viral Vector
Nucleic Acid
Vaccine

Preclinical
Early-Phase
Late-Phase & Commercialization
Commercial Services

News & Press Releases
Events & Webinars
Scientific Resources
Discover All

Search for:

Enter a term to search

Search for:

Events & Webinars

Meet our experts in person or online.

Events & Webinars

News & Press Releases Scientific Resources

All
Events
On-Demand Webinars

Search for:

Loading...

INFOGRAPHIC

Driving Success  from Preclinical to Commercial Approval & Beyond

A guide for early and late-stage development, commercialization, and lifecycle management

Coriolis Pharma Research GmbH
Fraunhoferstraße 18 b
82152 Martinsried, Germany
+49 89 41 77 60 – 0

Coriolis Pharma US Inc.
8 Davis Drive, Suite 324
Durham, NC 27713, United States
+1 919 823 9544

Stay Connected:

The Coriolis Effect
Our Facilities
Leadership Team
Our Journey
Careers

Drug Product Development
Analytical Services
Manufacturing Services

Antibody or Antibody-Related
Peptide
Therapeutic Protein
Gene & Cell Therapy
Viral Vector
Nucleic Acid
Vaccine
Nanoparticulate Delivery Systems

Preclinical
Early-Phase
Late-Phase & Commercialization
Commercial Services

Coriolis Pharma Research GmbH
Fraunhoferstraße 18 b
82152 Martinsried, Germany
+49 89 41 77 60 – 0

Coriolis Pharma US Inc.
8 Davis Drive, Suite 324
Durham, NC 27713, United States
+1 919 823 9544

Stay Connected:

Coriolis Pharma ©2026